Recombinant Avian Influenza Vaccine And Uses Thereof

Patent No. EP2367566 (titled "Recombinant Avian Influenza Vaccine And Uses Thereof") was filed by Biolex Therapeutics on Nov 30, 2009. The application was issued on Nov 27, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PRUJul 5, 2017GRAF VON STOSCH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2367566

BIOLEX THERAPEUTICS
Application Number
EP09760072A
Filing Date
Nov 30, 2009
Status
Patent Maintained As Amended
Oct 25, 2019
Publication Date
Nov 27, 2019